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Background: The mechanism underlying sperm PLC interaction with its target membrane is unresolved.
Results: EF-handmutations introduced into PLC reduce in vivoCa2 oscillation inducing activity and in vitro interaction with
PIP2.
Conclusion: EF-hand domain is essential for targeting PLC to PIP2-containing membranes.
Significance:We propose a novel mechanism by which sperm PLC is anchored to its physiological membrane substrate.
Sperm-specific phospholipase C- (PLC) is widely consid-
ered to be the physiological stimulus that triggers intracellular
Ca2 oscillations and egg activation during mammalian fertil-
ization. Although PLC is structurally similar to PLC1, it lacks
a pleckstrin homology domain, and it remains unclear how
PLC targets its phosphatidylinositol 4,5-bisphosphate (PIP2)
membrane substrate. Recently, the PLC1 EF-hand domainwas
shown to bind to anionic phospholipids through a number of
cationic residues, suggesting a potential mechanism for how
PLCsmight interactwith their targetmembranes. Those critical
cationic EF-hand residues in PLC1 are notably conserved in
PLC.We investigated the potential role of these conserved cat-
ionic residues in PLC by generating a series of mutants that
sequentially neutralized three positively charged residues (Lys-
49, Lys-53, and Arg-57) within the mouse PLC EF-hand
domain. Microinjection of the PLC EF-hand mutants into
mouse eggs enabled their Ca2 oscillation inducing activities to
be compared with wild-type PLC. Furthermore, the mutant
proteins were purified, and the in vitro PIP2 hydrolysis and
binding properties were monitored. Our analysis suggests
that PLC binds significantly to PIP2, but not to phosphatidic
acid or phosphatidylserine, and that sequential reduction of
the net positive charge within the first EF-hand domain of
PLC significantly alters in vivo Ca2 oscillation inducing
activity and in vitro interaction with PIP2 without affecting
its Ca2 sensitivity. Our findings are consistent with theoret-
ical predictions provided by a mathematical model that links
oocyte Ca2 frequency and the binding ability of different
PLC mutants to PIP2. Moreover, a PLC mutant with muta-
tions in the cationic residues within the first EF-hand domain
and the XY linker region dramatically reduces the binding of
PLC to PIP2, leading to complete abolishment of its Ca2
oscillation inducing activity.
During fertilization, the spermatozoon initiates activation of
egg development by triggering an acute rise in cytosolic free
Ca2 concentration (1). In mammals, this manifests as a series
of distinctive cytosolic Ca2 oscillations, beginning soon after
sperm-egg fusion and persisting for several hours (2). The
weight of evidence now suggests that Ca2 oscillations appear
to be caused by a sperm-specific protein, phospholipase C-
(PLC),3 which is introduced into the egg upon sperm-egg
fusion and leads to cycles of inositol 1,4,5-trisphosphate (IP3)
production following PIP2 hydrolysis, thus activating IP3 recep-
tor-mediated Ca2 release from intracellular stores in the egg
(3–12). The closest PLC homologue of sperm PLC is PLC1
(47% similarity, 33% identity), which is only able to cause Ca2
oscillations inmouse eggs at non-physiological concentrations,
because it has a50-fold lower potency (2, 3, 12). The superior
fertilization potency of the sperm PLC over somatic PLCs has
not yet been fully explained.
PLC is the smallest PLC with the simplest domain organi-
zation among all the mammalian isoforms. PLC consists of
four tandem EF-hand domains, the characteristic X and Y cat-
alytic domains in the center of the molecule, and a C-terminal
C2 domain. All these domains are common to the other PLC
isoforms (, , , , and ), but they appear to individually have
an essential role in the unique mode of regulation of this dis-
tinctive PLC isozyme (2). A notable structural difference
between PLC and the other somatic PLC isoforms is that PLC
lacks a pleckstrin homology (PH) domain at the N terminus (2,
3, 13). The membrane binding of somatic PLCs appears to be
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mediated by the PHdomain, awell defined structuralmodule of
120-amino acid residues identified in numerous proteins
(14). The PH domain of PLC1 is essential for interaction with
its phospholipid substrate PIP2 in the plasma membrane (15).
The absence of a PH domain from PLC sequence raises ques-
tions about how PLC can bind to membranes.
We have previously proposed that the PLCXY-linker, a seg-
ment between the X and Y catalytic domains that is notably
different from the corresponding XY-linker region of somatic
PLCs, is involved in the targeting of PLC to its membrane-
bound substrate PIP2 (16, 17). The XY-linker region of PLC is
extended in length and consists of more basic residues relative
to its PLC1 counterpart. The affinity of the XY-linker for PIP2
appears to involve a polybasic charged region that is found in a
number of othermembrane-associated proteins (16, 18). These
positively charged amino acids in the XY-linker appear to assist
the anchoring of PLC to membranes by enhancing the local
PIP2 concentration adjacent to the XY catalytic domain via
electrostatic interactions with the negatively charged PIP2 (16,
17). However, the XY-linker might not be the only domain that
mediates the binding of PLC to PIP2-containing membranes.
We have demonstrated that the absence of the XY-linker from
PLC significantly diminishes, but does not completely abolish,
the in vivoCa2 oscillation inducing activity (19). This suggests
that other domain(s)may also be involved in anchoring PLC to
its target membrane.
A recent study reported that the N-terminal lobe of the EF-
hand domain of PLC1 binds anionic phospholipids, and this
binding is due to interactions with cationic and hydrophobic
residues in the first EF-hand sequence of PLC1 (20). The
authors propose a general mechanism that may apply to other
PLC isoforms by suggesting that EF-hand domain interactions
with anionic phospholipids in the target membrane provides a
tether that facilitates proper substrate access and binding in the
active site (20). Importantly, the cationic residues in the first
EF-hand domain of PLC1 that contribute to anionic lipid ves-
icle binding are all conserved in PLC.
The aim of this study is to investigate the potential impor-
tance of a conserved cluster of cationic residues at the N-termi-
nal lobe of the EF-hand domain of PLC in association with
anionic lipids and its substrate PIP2. A series of full-length
mouse PLCmutants were prepared that sequentially neutral-
ized two positively charged lysine and one arginine residues
within the first EF-hand domain. The Ca2 oscillation-induc-
ing properties of these mutants were experimentally tested rel-
ative to wild-type PLC by microinjection of cRNA into unfer-
tilized mouse eggs. The various PLC mutants’ enzymatic
properties were analyzed using an in vitroPIP2 hydrolysis assay.
A protein-lipid overlay and a liposome binding/enzyme assay
were employed to assess the binding properties of wild-type
PLC to phosphatidylserine (PS), phosphatidic acid (PA),
and PIP2. Furthermore, the binding properties of mutant EF-
hand PLC proteins to PIP2were examined.Our results suggest
that PLC possesses significant affinity only for PIP2 but not for
PA or PS. We also find that sequential reduction of the net
positive charge within the first EF-hand domain significantly
reduces both in vivo Ca2 oscillation inducing activity and the
in vitro interaction of PLCwith PIP2. Moreover, we show that
a PLC mutant where three cationic residues within the first
EF-hand domain and three cationic residues within the XY-
linker region of PLC were substituted by alanine is unable to
trigger Ca2 oscillations in mouse eggs. In vitro biochemical
characterization suggests that this PLC mutant displays dra-
matically reduced binding to PIP2-containing liposomes com-
paredwith thewild-type PLC. Thus, we propose a novelmech-
anism for the sperm PLC interaction with PIP2-containing
membranes mediated by electrostatic interactions between the
anionic PIP2 with both the first EF-hand domain and the XY-
linker region of PLC, which are rich in cationic residues.
Experimental Procedures
Plasmid Construction—A pCR3-mouse PLC-luciferase
(PLC-luc) construct (21) was subjected to site-directed
mutagenesis (QuikChange II, Stratagene) to sequentially gen-
erate the three single, one double, and one triple substitutions
at Lys-49, Lys-53, and Arg-57, thus producing the PLCK49A,
PLCK53A, PLCR57A, PLCK49A,R57A, and PLCK49A,K53A,R57A
mutants.
pCR3-PLCK49A,K53A,R57A,K374A,K375A,K377A-luc construct
was generated by a three-step cloning strategy.
PLCEFK49A,K53A,R57A (1–149 amino acids) was amplified
from the PLCK49A,K53A,R57A-luc plasmid by PCR with prim-
ers to incorporate a 5-KpnI site and a 3-EcoRI site and then
cloned into the pCR3 vector. PLCEFK374A,K375A,K377A
(150–647 amino acids) was then amplified from the
PLCK374A,K375A,K377A-luc plasmid (17) with primers to
incorporate a 5-EcoRI site and a 3-NotI site in which the stop
codon had been removed and cloned into the pCR3-
PLCEFK49A,K53A,R57A plasmid. Finally, luciferase was ampli-
fied from pGL2 with primers incorporating NotI sites, and the
product was cloned into the NotI site of the pCR3-
PLCK49A,K53A,R57A,K374A,K375A,K377A plasmid.
All the above PLC mutants were amplified from their cor-
responding pCR3 plasmid with the appropriate primers to
incorporate a 5-SalI site and a 3-NotI site, and the products
were cloned into the pETMM60 vector to enable bacterial pro-
tein expression. The primers used for the amplificationswere as
follows: 5-GAACGTCGACATGGAAAGCCAACTTCATG-
AGCTCGC-3 (forward) and 5-GGAAGCGGCCGCTCACT-
CTCTGAAGTACCAAAC-3 (reverse). Successful mutag-
enesis and cloning of the above expression vector constructs
were confirmed by dideoxynucleotide sequencing (Applied
Biosystems Big-Dye Version 3.1 chemistry and model 3730 au-
tomated capillary DNA sequencer by DNA Sequencing &
ServicesTM).
cRNA Synthesis—Following linearization of wild-type and
mutated PLC plasmids, cRNA was synthesized using the
mMessage Machine T7 kit (Ambion) and then was polyadeny-
lated using the poly(A) tailing kit (Ambion), as per the manufa-
cturer’s instructions.
Preparation and Handling of Gametes—Female mice were
super-ovulated and mature MII eggs were collected from
excised oviducts 13.5–14.5 h after injection of human chorionic
gonadotrophin and maintained in droplets of M2 media
(Sigma) under mineral oil at 37 °C. Experimental recordings of
Ca2 release or luciferase expression were carried out with
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mouse eggs in Hepes-buffered media (H-KSOM), as described
previously (22). All compounds were from Sigma unless stated
otherwise. All procedures using animals were performed in
accordance with the United Kingdom Home Office Animals
Procedures Act and were approved by the Cardiff University
Animals Ethics Committee.
Microinjection and Measurement of Intracellular Ca2 and
Luciferase Expression—Mouse eggs were washed in M2 and
microinjected with cRNA diluted in injection buffer (120 mM
KCl, 20mMHepes, pH 7.4). The volume injected was estimated
from the diameter of cytoplasmic displacement caused by the
bolus injection. All injections were 3–5% of the oocyte volume.
Eggs were microinjected with the appropriate cRNA in the
injection buffer, mixed with an equal volume of 1 mM Oregon
Green 1,2-bis(2-aminophenoxy)ethane-N,N,N,N-tetraacetic
acid-dextran (Life Technologies, Inc.). Eggs were then main-
tained in H-KSOM containing 100 M luciferin and imaged on
aNikonTE2000microscope equippedwith a cooled intensified
CCD camera (Photek Ltd., UK). The luminescence (luciferase
expression) and fluorescence (for Ca2 measurements) from
eggs were collected by switching back and forth between the
twomodes on a 10-s cycle (23, 24). These two signals were then
displayed as two separate signals over the same time period for
each egg. The fluorescent light used to measure Ca2 is shown
in relative units. Luminescence was recorded as photon
counts/s and plotted as a running average over 5 min. All live
imaging experiments on eggs were made during a 1-month
period.
Protein Expression and Purification—For NusA-His6-fusion
protein expression, Escherichia coli (BL21-CodonPlus(DE3)-
RILP; Stratagene) cells were transformed with the appropriate
pETMM60plasmid and cultured at 37 °Cuntil theA600 reached
0.6, and protein expression was induced for 18 h at 16 °C with
0.1 mM isopropyl 1-thio--D-galactopyranoside (ForMedium).
Cells were harvested (6000 g for 10min), resuspended in PBS
containing a protease inhibitor mixture (EDTA-free; Roche
Applied Science), and sonicated four times for 15 s on ice. Sol-
uble NusA-His6-tagged fusion protein was purified on nickel-
nitrilotriacetic acid resin following standard procedures (Qia-
gen) and eluted with 250 mM imidazole. Eluted proteins were
dialyzed overnight (10,000 molecular weight cutoff; Pierce) at
4 °C against 4 liters of PBS and concentrated with centrifugal
concentrators (Sartorius; 10,000 molecular weight cutoff).
Assay of PLC Activity—PIP2 hydrolytic activity of recombi-
nant PLC proteins was assayed as described previously (17,
21). The final concentration of PIP2 in the reactionmixture was
220 M, containing 0.05 Ci of [3H]PIP2. The assay conditions
were optimized for linearity, requiring a 1-min incubation of
200 pmol of PLC protein sample at 25 °C. In assays to deter-
mine dependence on PIP2 concentration, 0.05 Ci of [3H]PIP2
was mixed with cold PIP2 to give the appropriate final concen-
tration. In assays examiningCa2 sensitivity, Ca2 buffers were
prepared by EGTA/CaCl2 admixture, as described previously
(17, 21).
Protein LipidOverlay Assay—PIP arraymembranes (Echelon
Biosciences) were blocked for 2 h with binding buffer (TBS-T:
20 mM Tris, 137 mM NaCl, 0.1% Tween 20, pH 7.4) containing
3% bovine serum albumin (lipid-free) and incubated with 25
pmol of each NusA-PLC fusion protein for 1 h at room tem-
perature. After washing three times in TBS-T, NusA-PLC
fusion protein interaction with the inositol phosphate lipids
was detected by first incubating the PIP array membranes with
penta-His monoclonal antibody (Qiagen, 1:5000 dilution in 5
ml of binding buffer) overnight at 4 °C, followed by three
15-minwashes. Thiswas followed by incubationwith horserad-
ish peroxidase-conjugated anti-mouse antibody in the same
binding buffer for 1 h at room temperature, followed by three
15-min washes with TBS-T. Detection of horseradish peroxi-
dase-coupled secondary antibodywas achieved using enhanced
chemiluminescence detection (ECL; Amersham Biosciences).
Liposome Preparation and Binding Assay—Unilamellar lipo-
somes were prepared as described previously (17, 25) by the
extrusion method using a laboratory extruder (LiposoFast-
Pneumatic, Avestin Inc., Ottawa, Ontario, Canada) with lipids
purchased from Avanti Polar Lipids Inc. (Alabaster, AL). In a
typical experiment for preparing a 2-ml dispersion of lipo-
somes, 0.038 mmol (19  103 M) of 1,2-dipalmitoyl-sn-
glycero-3-phosphocholine (PtdCho), 0.019 mmol (9.5  103
M) of cholesterol (CHOL; molar ratio of PtdCho/CHOL, 2:1),
0.0095 mmol (4.8  103 M) of 1,2-dimyristoyl-sn-glycero-3-
phosphoethanolamine (PtdEtn; molar ratio of PtdCho/PtdEtn,
4:1), and 5% 1,2-diacyl-sn-glycero-3-phospho-L-serine (PS) or
1–5% 1,2-diacyl-sn-glycero-3-phosphate sodium salt (PA) or
1% of 1,2-diacyl-sn-glycero-3-phospho-(1-D-myo-inositol 4,5-
bisphosphate) sodium salt (PIP2) were dissolved in a chloro-
form/methanol solution (2:1 v/v) for the formation of lipid
films. The filmwas hydrated with 2ml of PBS, and the resultant
suspension was extruded through two stacked polycarbonate
filters of 100-nmpore size. Twenty five cycles of extrusionwere
applied at 50 °C. Dynamic light scattering was employed to
determine the size of the liposomes, which used a light scatter-
ing apparatus (AXIOS-150/EX, Triton Hellas, Thessaloniki,
Greece) with a 30-milliwatt laser source and anAvalanche pho-
todiode detector set at a 90° angle. Dynamic light scattering
measurements of the extruded lipid preparation showed a nar-
rowmonomodal size distribution with average liposome diam-
eter of 100 nm and a polydispersity index of 0.20–0.25. For
protein binding studies, liposomes (100 g) were incubated
with 1 g of recombinant protein for 30 min at room temper-
ature and centrifuged for 5 h at 4 °C. The supernatant and pellet
were then analyzed either by SDS-PAGE and Coomassie Blue
staining or by the [3H]PIP2 hydrolysis assay described above.
SDS-PAGE and Western Blotting—Recombinant proteins
were separated by SDS-PAGE as described previously (25, 26).
Separatedproteinswere transferredontopolyvinylidenedifluo-
ride membranes (Immobilon-P; Millipore) using a semi-dry
transfer system (Trans-Blot S.D.; Bio-Rad) in transfer buffer (48
mM Tris, 39 mM glycine, 0.0375% SDS, 20% v/v methanol) at 20
V for 1 h.Membranes were incubated overnight at 4 °C in Tris-
buffered saline, 0.1% Tween 20 (TBS-T) containing 5% nonfat
milk powder, and probed with a penta-His mouse monoclonal
antibody (Novagen, 1:100,000 dilution). Detection of horserad-
ish peroxidase-coupled secondary antibody was achieved using
enhanced chemiluminescence detection (ECL; Amersham
Biosciences).
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Mathematical Modeling of Oocyte Ca2 Dynamics—Theo-
retical predictions of the oscillatory Ca2 activity associated
with the various PLC constructs were provided by a mathe-
maticalmodel of oocyte IP3/Ca2 dynamics. Themathematical
model, which has previously been presented in detail (25),
employs three inter-dependent variables, namely free cytosolic
Ca2, Ca2 sequestered in the endoplasmic reticulum, and
intracellular concentrations of IP3. To account for the specific
binding activity of each PLC variant, the effective activity of a
PLC concentration is defined as: VePLC	 VPLCb, where VPLC
is the nominal PLC concentration, and b is the binding activity
estimated experimentally for each construct. Coefficient b
assumes a value between 0 and 1, whereas VPLC can assume
values beyond the physiological range when the protein is over-
expressed. The mathematical model was coded and numeri-
cally integrated on both C and a MATLAB platform
(MathWorks).
Results
Effect of EF-hand Mutations on PLC-mediated Ca2 Oscil-
lations inMouse Eggs—To investigate the potential importance
of a cluster of cationic residues within the first EF-hand unit of
the first pair of PLC EF-hand domains (Fig. 1), we performed
site-directed mutagenesis to produce a panel of cumulative
mutations within this positively charged region of the full-
length mouse PLC. Thus, the residues Lys-49, Lys-53, and
Arg-57were sequentially substituted by the neutral amino acid,
alanine, to create three single (PLCK49A, PLCK53A, and
PLCR57A) mutants, as well as one double (PLCK53A,K57A) and
one triple (PLCK49A,K53A,R57A) PLCmutant. To test the Ca2
oscillation inducing activity of PLCK49A, PLCK53A, PLCR57A,
PLCK49A,R57A, and PLCK49A,K53A,R57A mutants and to verify
that these constructs were faithfully expressed as proteins in
cRNA-microinjected mouse eggs, we generated C-terminal
luciferase-tagged versions of these constructs to enable quanti-
tation of relative protein expression by luminescence detection
of the expressed PLC-luciferase fusion protein, as described
previously (17, 21). Prominent Ca2 oscillations were observed
in PLCWT-luciferase cRNA-injected mouse eggs (9.7 spikes in
the 1st h of oscillations) following successful protein expression
to a level indicated by a luminescence reading of 0.47 counts/s
(Fig. 2 and Table 1), in accord with previous reports (17, 21).
Microinjection of cRNA encoding the three single PLC
mutants (PLCK49A, PLCK53A, and PLCR57A) also triggered
Ca2 oscillations (Fig. 2), but these exhibited a lower frequency
relative to PLCWT (3.6, 4.4, and 4.3 spikes in the 1st h, respec-
tively), although the proteins were expressed at comparable
expression levels (Table 1). Similarly, egg microinjection with
cRNA encoding either the double PLCK49A,R57A or the triple
PLCK49A,K53A,R57A mutant resulted in a significant reduction
in the frequency of Ca2 oscillations compared with PLCWT,
causing 3.7 and 2.8 spikes/1 h, respectively, again when protein
was expressed at comparable levels (Fig. 2 and Table 1). These
data indicate that the substitution of even one Lys or Arg resi-
due for a neutral Ala within the positively charged cluster of the
PLC EF-hand domain can significantly alter their Ca2 oscil-
lation inducing activity in mouse eggs by reducing the fre-
quency of Ca2 spikes.
Overexpression of PLCK49A,K53A,R57A in Mouse Eggs Rescues
Its Defective Ca2Oscillation-inducing Phenotype—Judging by
the number of Ca2 spikes observed within the 1st h of oscilla-
tions per unit of recombinant fusion protein expression (cps),
PLCWT can be seen to be about 3.5 times more effective at
causing Ca2 oscillations than the PLCK49A,K53A,R57A triple
mutant. To investigate whether we could rescue the low fre-
quency of Ca2 oscillations induced by PLCK49A,K53A,R57A, we
overexpressed this PLC mutant in mouse eggs. As shown in
Fig. 3 and Table 1, the overexpression of PLCK49A,K53A,R57A
(7.65 cps) indeed led to 8.6 spikes in the 1st h of oscillations,
comparable with that for PLCWT, suggesting that loading the
egg with large amounts of this PLC mutant can rescue its
defective Ca2 oscillation-inducing phenotype.
Expression and Enzymatic Characterization of PLC EF-
hand Mutants—Each of the PLCK49A, PLCK53A, PLCR57A,
PLCK49A,R57A, and PLCK49A,K53A,R57A mutants was sub-
cloned into the pETMM60 vector and purified as NusA-His6
fusion proteins by affinity chromatography. We have recently
demonstrated that NusA is an effective fusion protein partner
for PLC, significantly increasing soluble expression of PLC
protein in E. coli, as well as enhancing the enzymatic stability of
the purified protein over time (11). Following expression of
NusA-PLC fusion proteins in E. coli and purification by nick-
el-nitrilotriacetic acid affinity chromatography, samples of
each protein were analyzed by SDS-PAGE followed by Coo-
massie Brilliant Blue staining and immunoblotting using an
FIGURE 1.Generation of PLC EF-handmutants. Schematic representation of the domain structure ofmouse PLC identifying the location of the successive
Lys or Arg residue substitutions to Ala, between residues 49 and 57 within the first EF-hand domain that are prepared by site-directed mutagenesis for this
study.
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anti-NusA monoclonal antibody. Fig. 4A shows that the major
protein band following affinity isolation, with mobility corre-
sponding to the predictedmolecularmass of134 kDa for each
construct, was present for all fusion proteins analyzed (left
panel), and these major bands were also recognized in the cor-
responding anti-NusA immunoblot (right panel), confirming
the appropriate expression of all PLCmutants. Some interme-
diate molecular mass bands detected by the anti-NusA anti-
body are the probable result of some degradation occurring
through the various protein expression and purification proce-
dures. Similarity of protein expression profile, including degra-
dation products, for the various PLC constructs being exam-
ined suggests that experimental comparison of relative
enzymatic data may be appropriate. Hence, the specific PIP2
hydrolytic enzyme activity for PLCWT and each recombinant
mutant protein was determined by the standard micellar
[3H]PIP2 hydrolysis assay. The histogram of Fig. 4B and Table 2
summarize the enzyme specific activity values obtained for
each recombinant protein. The enzymatic activities of all
recombinant proteins was very similar, suggesting that mutat-
ing the basic residues of the first pair of EF-hands to a neutral
residue has no effect on the ability of PLC to hydrolyze PIP2 in
vitro.Moreover, to investigate the impact of the EF-handmuta-
tions on Ca2 sensitivity of PLC enzyme activity, we assessed
the ability of these PLC recombinant proteins to hydrolyze
[3H]PIP2 at different Ca2 concentrations ranging from 0.1 nM
to 0.1 mM. These experiments indicated that there was no sig-
nificant difference in the Ca2 sensitivity of PIP2 hydrolysis for
thewild type, and the five EF-handmutants (Fig. 4C) with a very
similar EC50 value (67–85 nM) displayed by all recombinant
PLC proteins (Table 2). To compare the enzyme kinetics of
wild-type and mutant PLCs, the Michaelis-Menten constant,
Km, was calculated for each construct (Table 2). The Km values
obtained were similar for human PLCWT (84 M), PLCK49A
(121 M), and PLCR57A (115 M), whereas the Km value for
PLCK53A (169 M) and PLCK49A,R57A (219 M) mutants was
2- and 2.6-fold higher compared with that of PLCWT.
Interestingly, the Km value for PLCK49A,K53A,R57A (432 M)
was5.1-fold higher comparedwith PLCWT (84M), suggest-
ing that replacement of these three positively charged residues
within the first EF-hand domain affects the in vitro affinity of
PLC for PIP2 without affecting the Ca2 sensitivity of this
enzyme.
Binding of PLC to PS, PA, and PIP2—To examine the ability
of PLC to bind the membrane lipids, PS, PA, and PIP2, we
employed three different approaches. First, we used a protein-
lipid overlay assay to assess the binding of PLC to membrane-
spotted arrays of inositol phospholipids containing PS, PA, or
PIP2. As shown in Fig. 5A, no binding to PS or PA was evident,
although PLCwas able to bind tomembrane arrays containing
PIP2. This result is consistent with our liposome binding assays
(Fig. 5B). For these binding assays, we made unilamellar
liposomes composed of phosphatidylcholine/CHOL/phos-
FIGURE 2. Expression ofwild-type andmutant PLC constructs (PLCK49A,
PLCK53A, PLCR57A, PLCK53A,K57A, and PLCK49A,K53A,R57A) in unfertilized
mouse eggs. Fluorescence and luminescence (Lum) recordings reported the
Ca2 changes (red traces; Ca2) and luciferase expression ((black traces; lumi-
nescence, in counts/s), respectively, in unfertilized mouse eggs following
microinjection of cRNA encoding luciferase-tagged PLC constructs. Mean
number of Ca2 oscillations in the 1st h of oscillating (spikes) andmean lumi-
nescence (cps) in the 1st h of oscillating (Lum) are shown. a.u., arbitrary units.
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phatidylethanolamine (4:2:1) with incorporation of either 5%
PS, 1 or 5% PA, and 1% PIP2. To diminish any nonspecific pro-
tein binding to highly charged lipids, the liposome binding
assays were performed in the presence of a near-physiological
concentration of MgCl2 (0.5 mM). PLC displayed robust bind-
ing only to liposomes containing 1% PIP2, whereas the protein
was only detected in the supernatant of liposomes containing
5% PS and 1 or 5% PA (Fig. 5B). Finally, we incubated 1 g of
PLC recombinant proteinwith the liposomes composed of the
different phospholipids, and after centrifugation, the super-
natants were separated and assayed for their ability to hydro-
lyze PIP2 in vitro, using the standard [3H]PIP2 hydrolysis
assay. As shown in Fig. 5C, only the supernatant obtained
after the interaction of recombinant PLC protein with the
liposomes containing 1% PIP2 showed a dramatic 94%
reduction in its PIP2 hydrolytic activity. All these data sug-
gest that the PLC binds specifically to PIP2, not generically
to any anionic phospholipid.
FIGURE 3. Overexpression of PLCK49A,K53A,R57A in unfertilized mouse
eggs. The left panel shows representative fluorescence (a.u., arbitrary units)
and luminescence (cps) recordings reporting the Ca2 concentration
changes (red traces; Ca2) and luciferase expression (black traces; Lum),
respectively, in a mouse egg following microinjection of PLCK49A,K53A,R57A-
luciferase cRNA. The right panel shows an integrated image of luciferase
luminescence from eggs microinjected with the corresponding
PLCK49A,K53A,R57A-luciferase cRNA for the 1st h of recording. The mean lumi-
nescence in the 1st h of oscillating (Lum) andmean number of Ca2 spikes in
the 1st h of oscillating (spikes) are shown. a.u., arbitrary units.
FIGURE 4. Expression and enzymatic characterization of recombinant
NusA-His6-PLC EF-hand mutants. A, expression of recombinant NusA-
His6-PLC
WT and the variousmutant PLCproteins. Affinity-purified PLCpro-
teins (1 g) were analyzed by SDS-PAGE followed by either Coomassie Bril-
liant Blue staining (left panel) or immunoblot analysis using the anti-NusA
monoclonal antibody at 1:100,000 dilution (right panel). B, enzyme activity of
the various PLC mutants. PIP2 hydrolysis enzyme activities of the purified
NusA-His6-PLC fusion proteins were determined with the standard [
3H]PIP2
cleavage assay, n	 4
 S.E., using two different preparations of each recom-
binant protein. An unpaired Student’s t test showed no significant statistical
difference between the enzymatic activities of PLC and PLC EF-hand
mutants. In all cases, p  0.1. C, effect of varying [Ca2] on the normalized
activity of NusA-His6-tagged wild-type and mutant PLC fusion proteins. For
these assays, n	 4
 S.E., using two different preparations of each recombi-
nant protein.
TABLE 1
Properties of PLC-luciferase EF-handmutants expressed in unfertilized mouse eggs
Ca2 oscillation inducing activity (number of Ca2 spikes in the 1st h of oscillations) and luciferase luminescence levels (counts/s of luminescence in 1st h of oscillating) are
summarized for mouse eggs microinjected with each of the PLC-luciferase mutants as follows: PLCK49A, PLCK53A, PLCR57A, PLCK53A,R57A, PLCK49A,K53A,R57A,
PLCDMM, and wild type PLC-luciferase (see Figs. 2, 3, and 8B). The data are expressed to two significant figures, with means 
 S.E. Ratios of total luminescence
(counts) per spike in the 1st h of oscillating are also shown expressed to two significant figures with means 
 S.E. This is not shown where the number of spikes is
zero or where the expression of PLC is sufficiently high that the relationship between number of spikes and expression is no longer linear. The results of
Mann-Whitney tests for significant differences between the number of spikes for each of the wild-type and mutant PLC-luciferase constructs are indicated with
p values. The results of this same test for a significant difference between the PLC mutant ratios (counts/spike) and the wild-type PLC-luciferase ratio are also
denoted in this way. NA, not applicable.
PLC
cRNA
No. of
eggs
Mean no. of oscillations
in 1st h of spiking
Mean expression in
1st h of spiking
No. of spikes significantly
different from wild type?
Mean total counts/spike in 1st
h of oscillating (counts/spike)
Counts/spike significantly
different from wild type?
cps
PLCWT 31 9.7
 0.63 0.47
 0.038 NA 14.61
 2.05 NA
PLCK49A 19 3.6
 0.16 0.48
 0.024 Yes (p	0.001) 25.92
 1.17 Yes (p	0.001)
PLCK53A 39 4.4
 0.13 0.46
 0.014 Yes (p	0.001) 20.78
 0.85 Yes (p	0.001)
PLCR57A 30 4.3
 0.13 0.74
 0.032 Yes (p	0.001) 38.21
 2.1 Yes (p	0.001)
PLCK49A,R57A 30 3.7
 0.14 0.65
 0.030 Yes (p	0.001) 34.96
 1.94 Yes (p	0.001)
PLCK49A,K53A,R57A 43 2.8
 0.074 0.54
 0.031 Yes (p	0.001) 37.35
 2.24 Yes (p	0.001)
PLCK49A,K53A,R57A 11 8.6
 1.7 7.65
 0.92 No (p	 0.15) NA NA
PLCDMM 25 0
 0 0.53
 0.046 Yes (p	0.001) NA NA
PLCDMM 20 0
 0 14.43
 0.80 Yes (p	0.001) NA NA
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Binding of PLC EF-hand Mutants to PIP2-containing
Liposomes—To investigate the effect of cumulative EF-hand
mutations on the PIP2-binding properties of wild-type PLC,
we employed the liposome/activity binding assay as described
above (see Fig. 5C). Thus, 1 g of recombinant protein corre-
sponding to PLCWT and the five EF-hand mutants were each
incubated with liposomes containing 1% PIP2. After centrifu-
gation, the supernatants were separated, and the PIP2 hydro-
lytic activitywas assayed using the standard [3H]PIP2 hydrolysis
assay. Based on the percentage of the PIP2 hydrolytic activity
pre- and post-liposomebinding, we estimated the relative bind-
ing of each PLC protein to the PIP2-containing liposomes. As
shown in Fig. 6, although 94% of PLCWT bound to the lipo-
somes, the three single EF-handmutants (PLCK49A, PLCK53A,
and PLCR57A) showed71–75% liposome binding. The effect
of the double and the triplemutation was evenmore notable, as
PLCK53A,K57A displayed59% and PLCK49A,K53A,R57A49%
relative liposome binding. These data indicate that sequential
neutralization of the basic residues within the EF-hand region
substantially reduces the PIP2-binding ability of PLC.
Modeling of Ca2 Oscillations Induced by PLC EF-hand
Mutants—The Ca2 oscillatory activity associated with each of
the PLC mutants constructed was simulated by using the
parameters calculated in Fig. 6 and Tables 1 and 2. The most
marked differentiation between constructs is the binding activ-
ity of each protein (Fig. 6), which is in agreement with a pro-
gressive destabilization of the EF-hand binding regime. By con-
trast, the Ca2 dependence of IP3 production (plotted in Fig. 4
and quantified inTable 2 asCa2-dependent EC50 value) is very
similar for each of the PLC constructs. Ca2 oscillations sim-
ulated with this set of parametric values (Fig. 7, top panel)
closelymatch those observed experimentally for each construct
(Fig. 2) in terms of frequency. The theoretical relationship
between Ca2 oscillatory frequency and binding activity was
produced by the mathematical model for EC50	 65, 75, and 85
nM (Fig. 7, bottom panel,, lines left to right). The experimentally
computed operating points of PLC wild-type and its various
constructs (Fig. 7, bottom panel, circles) are located very close
to the theoretical curves, confirming that the variability in
Ca2 oscillatory frequency can be accounted for almost exclu-
sively by the gradual reduction in binding activity. When
PLCK49A,K53A,R57A was highly overexpressed, the oscillatory
activity was largely restored, as indicated by the operating point
of this scenario (Fig. 7, bottom panel, solid circle at the right of
the panel). The fact that the circle lies below the theoretical
frequency curve (Fig. 7, bottom panel, dashed line) may be due
to the sub-optimal binding of the protein to PIP2 at non-phys-
iologically elevated concentrations.
Ca2 Oscillation Inducing Activity of PLC Double Motif
Mutant Expressed inMouse Eggs—To investigatewhether there
is synergy between the cationic residues of the first EF-hand
FIGURE 5. In vitro binding of wild-type PLC to PS, PA and PIP2. A, PLC
protein-lipid overlay assays. Recombinant protein binding to spotted phos-
pholipids on the PIP arrays was detected using the monoclonal penta-His
antibody. B, liposome “pulldown” assay of PLC. Unilamellar liposomes con-
taining either PS (5%), or PA (1 or 5%), or PIP2 (1%) were incubated with PLC
recombinant protein. Following liposome centrifugation, both the superna-
tant (s) and liposome pellet (p) were subjected either to SDS-PAGE and Coo-
massie Brilliant Blue staining. C, supernatants were assayed for their ability to
hydrolyze PIP2 in vitro, using the standard [
3H]PIP2 hydrolysis assay, n	 4

S.E., using two different preparations of recombinant protein. Significant sta-
tistical differences (asterisks) were calculated by an unpaired Student’s t test;
***, p 0.0005 (GraphPad, Prism 5).
TABLE 2
In vitro enzymatic properties of NusA-His6-PLC EF-handmutants
Summary of specific enzyme activity and Km and EC50 values of Ca2 dependence
for PIP2 hydrolysis determined by non-linear regression analysis (GraphPad Prism
5) for the NusA-His6 fusion proteins (see Figs. 4 and 9) is shown.
PLC
protein
PIP2 hydrolysis
enzyme activity
Ca2 dependence
EC50 Km
nmol/min/mg nM M
PLCWT 544
 23 72 84
PLCK49A 525
 28 68 121
PLCK53A 541
 22 75 169
PLCR57A 547
 30 85 115
PLCK49A,R57A 515
 17 67 219
PLCK49A,K53A,R57A 555
 30 79 432
PLCDMM 434
 28 108 4975
FIGURE6.BindingofPLCmutants toPIP2-containing liposomes.Normal-
ized binding of PLCWT, PLCK49A, PLCK53A, PLCR57A, PLCK53A,K57A, and
PLCK49A,K53A,R57A to unilamellar liposomes containing 1% PIP2 is shown. Fol-
lowing centrifugation, the supernatants were assayed for their ability to
hydrolyze PIP2 in vitro, using the standard [
3H]PIP2 hydrolysis assay (n	 4

S.E., using two different preparations of recombinant protein). Based on the
percentage of the PIP2 hydrolytic activity pre- and post- liposome binding,
the relative binding of each PLC protein to the PIP2-containing liposomes
was determined. Significant statistical differences (asterisks) were calculated
by an unpaired Student’s t test; *, p 0.05; **, p 0.005; and ***, p 0.0005,
(GraphPad, Prism 5).
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domain and the XY-linker region of PLC and whether these
residues are necessary and sufficient to anchor this sperm
protein to its PIP2-containing membranes, we generated a
PLC mutant, in which charge-neutralization mutations
were introduced within these two PLC motifs. Thus, the
residues Lys-49, Lys-53, and Arg-57 within the first EF-hand
domain and the residues Lys-374, Lys-375, and Lys-377 within
the XY-linker of PLC were substituted by the neutral Ala
residue giving rise to a PLC double motif mutant
(PLCK49A,K53A,R57A,K374A,K375A,K377A; PLCDMM) containing
six neutralization mutations (Fig. 8A). Interestingly, microin-
jection of cRNA encoding a luciferase-tagged version of
PLCDMM failed to cause any Ca2 release, even after relatively
high levels of protein expression in unfertilized mouse eggs
(Fig. 8B and Table 1).
To investigate whether the luciferase-tagged PLCWT and
PLCDMM fusion constructs were expressed as structurally
intact proteins inmouse eggs, we performed immunoblot anal-
FIGURE7.Simulated timeseriesofCa2oscillationswithinanegg forwild-typeandthevariousPLCmutants.Toppanel,physiological parameterswere taken
fromexperimentalmeasurements summarized in Fig. 6 andTables 1 and2. The theoretical relationshipbetweenPIP2 binding activity of the PLC constructs and the
Ca2 oscillatory frequency is plotted in the bottompanel as a solid line for EC50	 75 nM. The solid curve is framedby two dotted lines corresponding to EC50	 65 and
85nM(leftand rightpanels, respectively) toaccount for thesmallvariability inEC50estimatedfor thevariousconstructs (indicatedbycircles). Thecurve isplottedagainst
a normalized rangeof 0 to 1 to account for thebindingactivity estimatedas apercentile in Fig. 6.Oscillatory activity associatedwithoverexpressedPLCK49A,K53A,R57A
is indicated by the solid circle (top right). This point lies below the theoretical binding activity versus frequency curve (dashed line).
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ysis of two groups of mouse eggs microinjected with 0.5 g/l
cRNA encoding either PLCWT-LUC or the PLCDMM-LUC
mutant. Expression was followed for 3 h and then the two
groups of eggs were analyzed by SDS-PAGE and immunoblot
detection using an anti-luciferase antibody. A single protein
band was observed with mobility corresponding to the pre-
dicted molecular mass (129 kDa) for both PLCWT-LUC and
PLCDMM-LUC fusion proteins (Fig. 9), suggesting that each of
the two cRNAs was faithfully expressed as full-length PLC-lu-
ciferase proteins and at similar expression levels in the cRNA-
injected mouse eggs.
Expression, Enzymatic Characterization, and in Vitro Bind-
ing of PLC Double Motif Mutant to PIP2-containing
Liposomes—PLCDMMwas then subcloned into the pETMM60
vector and bacterially expressed and purified as a NusA-His6-
tagged fusion protein. Fig. 10A shows NusA-His6-PLCDMM
recombinant protein analyzed by SDS-PAGE (left panel) and
immunoblot detection with the anti-NusA monoclonal anti-
FIGURE8.GenerationandexpressionofPLCK49A,K53A,R57A,K374A,K375A,K377A (PLCDMM) inunfertilizedmouseeggs.A, schematic representationofmouse
PLC domain structure identifying the location of the successive Lys or Arg residue substitutions to Ala, between residues 49 and 57 within the first EF-hand
domain, as well as the location of the successive Lys substitutions to Ala between residues 374 and 379 in the XY-linker region. B, traces showing the changes
in fluorescence (a.u., arbitrary units) and luminescence (cps) denoting alterations in Ca2 concentrations (red trace) and luciferase expression (black trace),
respectively, following the microinjection of high and low concentrations of PLCDMM-luciferase cRNA into unfertilized mouse eggs. The mean values for the
number of Ca2 oscillations (spikes) and luminescence (Lum) during the 1st h of oscillating are shown.
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body (right panel). The corresponding protein with the appro-
priatemolecularmass (134 kDa)was observed as the top band
in both Coomassie Brilliant Blue staining and on the immuno-
blot (Fig. 10A). Some low molecular weight bands were also
detected by the anti-NusA antibody, and these are probably the
result of protein degradation occurring through the bacterial
expression and purification processes. Enzymatic analysis
using the [3H]PIP2 hydrolysis assay showed that PLCDMM
retained80% of the enzymatic activity of PLCWT (434
 28
versus 544
 23 nmol/min/mg) (Fig. 10B) and that there was no
significant difference in the Ca2 sensitivity of PIP2 hydrolysis
for PLCWT and PLCDMM, with a very similar EC50 value (72
versus 108 nM) (Fig. 10C and Table 2). However, the Km value
for PLCDMM (4975 M) was 59-fold higher compared with
PLCWT (84 M). More interestingly, when we performed the
liposome/activity binding assay for PLCDMM, we found that
this mutant displayed only 15% relative liposome binding
compared with PLCWT (Fig. 10D). These data indicate that
neutralization of the positively charged residues within the first
EF-hand and the XY-linker region dramatically reduces the
binding of PLC to PIP2, leading to complete loss of its in vivo
Ca2 oscillation inducing activity.
Discussion
A significant body of scientific and clinical evidence suggests
that the sperm-specific PLC protein is the physiological mol-
ecule that, following sperm-egg fusion, stimulates cytoplasmic
Ca2 oscillations, egg activation, and early embryonic develop-
ment to effect mammalian fertilization (3, 5, 7, 8, 11, 21, 27).
The most compelling observation is that solely introducing
PLC mimics all of the signaling processes initiated by the
sperm, triggering the same pattern of Ca2 release as seen at
normal fertilization and leading to the successful development
of a blastocyst embryo. Thus, the current model of egg activa-
tion at fertilization is that the PLC of a fertilizing spermato-
zoon is introduced into the egg cytoplasm where it catalyzes
PIP2 hydrolysis, stimulating the IP3 signaling pathway, and
leading to Ca2 oscillations (5, 13).
The sperm PLC is the smallest, with the most elementary
domain organization, of all the mammalian PLC isoforms (3).
Hence, the intrinsic ability of sperm PLC to cause robust Ca2
oscillations in eggs is significant because all the other PI-spe-
cific PLCs are unable trigger Ca2 oscillations in eggs at phys-
iological protein expression levels. It therefore appears most
plausible that PLC employs a novel mechanism to potently
induce Ca2 release in eggs and each of its individual domains
appears to play an important role in the distinct molecular and
biochemical characteristics, as well as in the unique regulatory
mechanism of this sperm-derived PLC isozyme (2, 12). PLC
shares the greatest homology with PLC1, but onemajor struc-
tural difference that distinguishes PLC from PLC1 is the lack
of an N-terminal PH domain (2, 13). This is mechanistically
interesting because the PH domain of PLC1 in particular is
known to specifically bind PIP2 in the plasma membrane (15,
28). In contrast, we have recently shown that PLC does not
localize to the plasma membrane-bound PIP2, but instead it
targets distinct vesicular structures inside the egg cortex (29).
Interestingly, the chimeric addition of a PH domain at the N
terminus of the PLC sequence does not alter the ability of
PLC to trigger Ca2 oscillations in mouse eggs, and the
PH-PLC chimera is unable to target PLC to the plasmamem-
brane PIP2 (25). The precise mechanism employed by PLC to
enable interaction with the PIP2-containing vesicular mem-
branes inside the egg cytosol is not understood.
Although the precise identity of the intracellular PIP2-con-
taining vesicles is currently unknown, we have proposed that
PLC associates with vesicular PIP2 via electrostatic interac-
tions mediated by the positively charged XY-linker region,
assisting in anchoring PLC to membranes, while enhancing
local concentrations of the negatively charged PIP2 (16, 17). In
PLC, the XY-linker region is more extended compared with
that of PLC1, and the proximal part to the Y catalytic domain
contains a distinctive cluster of basic amino acid residues not
found in the homologous region of any of the other somatic PLC
isoforms (3). It is also notable that the XY-linker of somatic PLCs
confers potent inhibition of their enzymatic activity (30, 31). In
contrast, the XY-linker of PLC does not confer enzymatic auto-
inhibitionbutconversely appears tobe required formaximal enzy-
matic activity (19).We have recently shown that deletion of PLC
XY-linker significantly diminishes its in vivo Ca2 oscillation
inducing activity but does not completely abolish it (19). This sug-
gests that the XY-linker is essential for the association of PLC
with PIP2-containing vesicular membranes, but it is not the sole
region of PLC responsible for this association.
Another candidate region that might be involved in the
sequestration of PLC to membranes containing its substrate
PIP2 is the C2 domain. The current data indicate that the C2
domain of PLCmay interact, albeit with low affinity, with mem-
brane phospholipids (17, 32). Indeed, such interactions were
observed in vitro with phosphatidylinositol 3-phosphate and
phosphatidylinositol 5-phosphate. It is possible that the associa-
tionof theC2domainwithphosphatidylinositol 3-phosphatemay
FIGURE 9. Confirmation of expression of PLCWT- and PLCDMM-LUC
fusionproteins inmouseeggs. Two sets ofmouse eggs (50 eggs each)were
microinjected with 0.5 g/l cRNA corresponding to either PLCWT or
PLCDMM. Expression was allowed for 3 h, and then the two sets of eggs
were analyzed by SDS-PAGE and Western blotting using an anti-firefly lucif-
erase antibody (1:10,000; Pierce).
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play a role in PLC localization, or even perhaps regulation of
enzymatic activity, as thepresenceofphosphatidylinositol 3-phos-
phate reduced PIP2 hydrolysis by PLC in vitro (32).
A recent study demonstrated that the N-terminal lobe of the
EF-hand domain of PLC1 binds to anionic phospholipid-con-
taining vesicles, suggesting that the EF-hand domain aids sub-
strate binding in the active site when the protein is membrane-
anchored (20). The binding of the PLC1 EF-hand domain to
anionic phospholipid is mediated by a number of cationic resi-
dues within the first EF-handmotif of PLC1. Interestingly, the
positively charged residues that have been shown to contribute
to the binding of PLC1 (Arg-182, Lys-183, and Arg-186) by
vesicles containing anionic lipids are specifically conserved in
PLC. We have shown that PLC EF-hand domains play an
important role in the high Ca2 sensitivity relative to the other
PLC isoforms, especially in comparison with PLC1 (21). PLC
appears to be 100-fold more sensitive to Ca2 than PLC1,
whichwould enable the enzyme to be active at the resting nano-
molar Ca2 levels within the egg cytosol (21). Deletion of one or
both pairs of EF-hand domains of PLC completely abolishes its
Ca2 oscillation inducing activity in mouse eggs (21). Our cur-
rent data suggest that this might be the result of both altered
Ca2 sensitivity and loss of ability to associate with PIP2-con-
tainingmembranes, as these PLC EF-hand deletion constructs
were unable to triggerCa2 release evenwhen overexpressed in
mouse eggs (21). Our mutagenesis analysis indicates that the
substitution of even one Lys or Arg residue to Ala within the
positively charged cluster of the PLC EF-hand domain dimin-
ishes the Ca2 oscillation inducing activity of PLC (Fig. 2)
without affecting its ability to hydrolyze PIP2 in vitro or the
Ca2 sensitivity of its enzymatic activity (Fig. 4). Interestingly,
theKm value for the triplemutant PLCK49A,K53A,R57A (432M)
was5.1-fold higher comparedwith PLCWT (84M), suggest-
ing that replacement of these three positively charged residues
within the first EF-hand domain has an effect on the in vitro
binding ability of PLC to PIP2 (Table 2). Moreover, we used a
variety of approaches and demonstrated that PLC binds
only to PIP2-containing liposomes, and sequential neutral-
ization of these basic residues within the first EF-hand
region of PLC can significantly diminish the PIP2-binding
ability of PLC (Figs. 5 and 6). As shown in our proposed
mechanism in Fig. 11, which is supported by our studies on the
PLCK49A,K53A,R57A,K374A,K375A,K377A mutant (PLCDMM), it is
plausible that PLC is attracted to the anionic PIP2-containing
FIGURE 10. Expression, enzymatic characterization and in vitro binding of NusA-His6-PLC
DMM to PIP2-containing liposomes. A, expression of recombinant
PLCDMM protein. Affinity-purified NusA-His6-tagged PLC
DMM protein (1 g) was analyzed by SDS-PAGE followed by either Coomassie Brilliant Blue staining (left
panel) or immunoblot analysis using the anti-NusA monoclonal antibody at 1:100,000 dilution (right panel). B, enzyme activity of PLCDMM. PIP2 hydrolysis enzyme
activities of the purified recombinant proteins were determined with the standard [3H]PIP2 cleavage assay, n	 4
 S.E., using two different preparations of each
recombinant protein. Significant statistical differences (asterisks) were calculated by an unpaired Student’s t test; *, p 0.05 (GraphPad, Prism 5). C, effect of varying
[Ca2] on the normalized activity of NusA-His6-tagged PLC
DMM fusion protein. For these assays n	 4
 S.E., using two different preparations of each recombinant
protein. D, normalized binding of PLCDMM to unilamellar liposomes containing 1% PIP2 (n	 4
 S.E., using two different preparations of recombinant protein).
Significant statistical differences (asterisks) were calculated by an unpaired Student’s t test; ***, p 0.0005, (GraphPad, Prism 5).
FIGURE11.Schematic illustrationof theproposedmechanismthatPLCuti-
lizes to target intracellular vesicular PIP2-containing membranes. Associa-
tion of PLCwith the negatively charged PIP2 involves electrostatic interactions
with the positively charged first EF-hand domain and the XY-linker region. The
catalytic XYdomain subsequentlyproceedswith theenzymatic cleavageof PIP2.
PIP2 Binding by PLC- Involves EF-hand Domain
DECEMBER 4, 2015•VOLUME 290•NUMBER 49 JOURNAL OF BIOLOGICAL CHEMISTRY 29529
 at U
N
IV
 W
A
LES CO
LL O
F CA
RD
IF on D
ecem
ber 16, 2015
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
component of the intracellular vesicular membranes through
electrostatic interactions with both the first EF-hand domain
and the XY-linker regions, which are rich in basic residues.
Our study provides an important advance in understanding
the complex regulatory mechanism of PLC and suggests that
the N-terminal lobe of the EF-hand domain of PLC has an
essential role in the interaction of this enzyme with its target
membrane, which together with the XY-linker may combine to
provide a tether that facilitates proper PIP2 substrate access and
binding in the PLC active site.
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